Benzoyl Peroxide Shortage: What Providers and Prescribers Need to Know in 2026

Provider Briefing: Benzoyl Peroxide Availability in 2026

Benzoyl Peroxide — one of the most universally recommended acne treatments across dermatology, primary care, and pediatrics — has experienced unprecedented supply disruption over the past two years. While the situation is stabilizing, the downstream effects on patient access, product trust, and clinical decision-making remain relevant in 2026.

This briefing covers the timeline of events, current availability, prescribing implications, and resources to help your patients access treatment.

Timeline: How We Got Here

March 2024: Valisure Citizen Petition

Independent testing laboratory Valisure filed a citizen petition with the FDA reporting that Benzoyl Peroxide products could form benzene, a Group 1 carcinogen, during storage — particularly at elevated temperatures. Their testing showed benzene levels exceeding FDA limits in multiple commercial products across OTC and prescription formulations.

Late 2024 - Early 2025: FDA Investigation and Voluntary Recalls

The FDA conducted its own testing and confirmed elevated benzene levels in specific product lots. This triggered voluntary recalls from several manufacturers:

• La Roche-Posay — Effaclar Duo Dual Action Acne Treatment (Lot MYX46W)
• Proactiv — Emergency Blemish Relief Cream and Skin Smoothing Exfoliator
• Walgreens — Acne Control Cleanser and Tinted Acne Treatment Cream
• SLMD Skincare — Benzoyl Peroxide Acne Lotion
• Zapzyt — Acne Treatment Gel

The FDA issued guidance reminding manufacturers of their responsibility to test for benzene contamination and ensure product stability across expected storage conditions.

2025-2026: Reformulation and Recovery

Manufacturers have been reformulating products to improve thermal stability and prevent benzene degradation. Newer products use improved packaging, adjusted pH levels, and in some cases microencapsulation technology to enhance stability. Recovery is ongoing, with most major brands back on shelves, though some recalled products have not yet returned.

Prescribing Implications

OTC Benzoyl Peroxide Remains First-Line

Despite the recalls, the FDA continues to classify Benzoyl Peroxide as Generally Recognized as Safe and Effective (GRASE) for acne. The American Academy of Dermatology (AAD) 2024 guidelines continue to recommend it as first-line therapy, both as monotherapy and in combination regimens.

The benzene concern is a product stability issue, not an intrinsic safety issue with the active ingredient. Providers should reassure patients that properly stored, non-recalled Benzoyl Peroxide products remain safe.

Patient Counseling Points

When prescribing or recommending Benzoyl Peroxide, consider adding these counseling points:

• Storage: Store at room temperature (below 77°F / 25°C). Do not leave in hot cars, near windows, or in humid bathrooms.
• Product selection: Recommend established brands with confirmed reformulation (e.g., PanOxyl, CeraVe, Neutrogena). Advise patients to check lot numbers against recall lists.
• Concentration: Clinical evidence supports 2.5% Benzoyl Peroxide as equally effective to 10% for bactericidal activity against C. acnes, with less irritation.
• Bleaching: Remind patients that Benzoyl Peroxide bleaches fabrics, towels, and hair.

Combination Therapy Considerations

For patients requiring prescription-strength acne treatment, the following combination products remain available and may offer more consistent supply through pharmacy distribution channels:

• Epiduo / Epiduo Forte (Adapalene 0.1-0.3% + Benzoyl Peroxide 2.5%) — First-line combination per AAD guidelines
• BenzaClin (Clindamycin 1% + Benzoyl Peroxide 5%) — Useful for inflammatory acne
• Duac (Clindamycin 1% + Benzoyl Peroxide 5%) — Once-daily gel formulation
• Onexton (Clindamycin 1.2% + Benzoyl Peroxide 3.75%) — Lower BP concentration
• Twyneo (Tretinoin 0.1% + Benzoyl Peroxide 3%) — Novel microencapsulated combination
• Cabtreo (Adapalene 0.15% + Clindamycin 1.2% + Benzoyl Peroxide 3.1%) — Triple-combination, once-daily

When prescribing combinations containing topical antibiotics, Benzoyl Peroxide should be maintained in the regimen to prevent antibiotic resistance development.

Current Availability Picture

As of early 2026:

• Widely available: PanOxyl (all formulations), generic BP gel/wash (2.5%, 5%, 10%), CeraVe Acne Foaming Cleanser, Neutrogena Stubborn Acne products
• Limited or regional: Some La Roche-Posay Effaclar products, certain store-brand formulations, Proactiv products
• Prescription products: Generally available through standard pharmacy channels

For real-time availability data, direct patients to Medfinder to check stock by location.

Cost and Access Considerations

Benzoyl Peroxide remains one of the most cost-effective acne treatments:

• OTC products: $5-$16 per unit
• Generic Rx (5% gel, 60g): $15-$40 cash; $15-$16 with discount cards
• Combination Rx products: $150-$500+ cash; most covered with formulary copays

For patients facing cost barriers:

• Discount cards: SingleCare, GoodRx, RxSaver
• OTC alternatives: Clinically equivalent to prescription stand-alone formulations
• Patient assistance: NeedyMeds and RxAssist for qualifying patients

Share with patients: How to Save Money on Benzoyl Peroxide.

Tools and Resources for Providers

Medfinder for Providers offers tools to help your practice navigate medication availability:

• Real-time pharmacy stock data — Check which pharmacies have specific products before prescribing
• Patient communication resources — Shareable guides on finding medications and saving money
• Alternative medication references — Quick-reference guides for switching between formulations

Additional provider resources:

• How to Help Your Patients Find Benzoyl Peroxide in Stock: A Provider's Guide
• How to Help Patients Save Money on Benzoyl Peroxide: A Provider's Guide

Looking Ahead

The Benzoyl Peroxide market continues to evolve:

• Regulatory developments: The FDA may issue updated stability testing guidance for BP products
• New delivery technologies: Microencapsulation is likely to become more widespread
• Combination products: Multi-ingredient, once-daily formulations continue to simplify acne treatment

Final Thoughts

Benzoyl Peroxide remains a cornerstone of acne management. The benzene issue was a product stability concern — not a fundamental safety problem. As availability normalizes, providers can help patients by recommending reliable products, counseling on storage, and connecting patients with tools like Medfinder for Providers.

For patient-facing resources, see our Benzoyl Peroxide educational content library.